| | Nondiabetics () | Diabetics () | value |
| Clinical characteristics | | | | Age (years), mean (SD) | 78 (9) | 78 (8) | 0.55 | Male sex, n (%) | 73 (44.5) | 73 (44.5) | 1.00 | LVSD, n (%) | 106 (64.6) | 106 (64.6) | 1.00 | Arterial hypertension history, n (%) | 111 (67.7) | 145 (88.4) | <0.001 | Atrial fibrillation, n (%) | 85 (51.8) | 65 (39.6) | 0.04 | Ischemic etiology, n (%) | 56 (34.1) | 77 (47.0) | 0.02 | NYHA class (IV versus others), n (%) | 97 (59.1) | 95 (57.9) | 0.91 | Heart rate (bpm), mean (SD) | 90 (25) | 88 (22) | 0.48 | Systolic blood pressure (mmHg), mean (SD) | 133 (31) | 137 (28) | 0.24 | BMI (Kg/m2), mean (SD) | 25.1 (4.3) | 26.6 (4.6) | 0.005 | Laboratory parameters at admission | | | | Haemoglobin (g/dL), mean (SD) | 12.0 (2.2) | 11.4 (2.2) | 0.02 | Sodium (mEq/L), mean (SD) | 137 (4) | 137 (5) | 0.94 | Urea (mg/dL), mean (SD) | 74 (40) | 83 (46) | 0.07 | Creatinine (mg/dL), mean (SD) | 1.50 (0.63) | 1.64 (0.68) | 0.06 | C-reactive protein (mg/L), median (IQR) | 21.1 (10.2–63.6) | 19.0 (9.9–61.3) | 0.73 | Total cholesterol (mg/dL), mean (SD) | 164 (45) | 147 (41) | 0.002 | BNP (ng/L), median (IQR) | 1664.1 (905.7–2635.7) | 1394 (773.3–2456.8) | 0.10 | Discharged BNP (ng/L), median (IQR) | 753.0 (280.7–1237.6) | 688.0 (275.0–1335.2) | 0.51 | Nonresponse, n (%) | 40 (24.4) | 50 (30.5) | 0.44 | Echocardiographic parameters | | | | LV mass (g), mean (SD) | 236.9 (84.8) | 231.1 (51.2) | 0.44 | Left atrium size (mm), mean (SD) | 4.9 (0.8) | 4.7 (0.5) | 0.14 | LV end-diastolic diameter (mm), mean (SD) | 5.7 (1.0) | 5.6 (0.8) | 0.14 | E/E’, median (IQR) | 16 (12–21) | 19 (13–23) | 0.27 | Discharge medication | | | | ACEi or ARB, n (%) | 120 (76.2) | 142 (86.6) | 0.004 | Beta blocker, n (%) | 125 (76.2) | 129 (78.7) | 0.69 | MRA, n (%) | 43 (26.2) | 30 (18.3) | 0.09 | Loop diuretics, n (%) | 151 (92.1) | 157 (95.7) | 0.45 | Furosemide dose (mg/day), median (IQR) | 80 (40–100) | 80 (60–120) | 0.02 | Statins, n (%) | 90 (60.4) | 117 (71.3) | 0.03 | Antiplatelet therapy, n (%) | 100 (61.0) | 124 (75.6) | 0.01 | Mortality at 1 year, n (%) | 44 (26.8) | 46 (28.0) | 0.89 |
|
|